Capsicum oleoresin
CAS 8023-77-6
Capsicum oleoresin (CAS 8023-77-6) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Capsicum oleoresin is linked to DTXSID90897325 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CAPSICUM OLEORESIN | 235787 | SU | MTHSPL |
| Capsicum oleoresin | 235787 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Capsicum oleoresin used for in pharmaceutical contexts?
Capsicum oleoresin (CAS 8023-77-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Capsicum oleoresin?
Capsicum oleoresin has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Cerebrovascular accident. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Capsicum oleoresin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for CAPSICUM FRUTESCENS RESIN with EU status "permitted".
What clinical phase is Capsicum oleoresin in?
No phase 1-4 clinical development badge is rendered for Capsicum oleoresin because the matched compound identifier rows do not contain a max-phase value.